Rapacuronium administration to two children with Duchenne's muscular dystrophy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10866881.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Children with Duchenne's muscular dystrophy should not be exposed to succinylcholine because of the risk of hyperkalemic cardiac arrest and rhabdomyolysis. This report describes the response to rapacuronium bromide in two patients with Duchenne's muscular dystrophy. Both patients had a recovery index 2 times longer than that reported in children with normal neuromuscular function.
Medical subject headings
- Anesthesia, General
- Muscular Dystrophy, Duchenne
- Neuromuscular Blocking Agents
- Vecuronium Bromide